Skip to content
Shop Now
Search
Search
Close
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
About
Shop
Videos
Publications
Supplements
Donate
Contact
×
Home
About
Shop
Videos
Publications
Supplements
Donate
Contact
Search
Search
Close
Shop Now
Home
About
Shop
Videos
Publications
Supplements
Donate
Contact
Home
/
Publications
/ S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis
S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis
$
0.00
S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis quantity
Add to cart
Category:
Publications
Related products
S551 Loss of Bifidobacteria in Lyme Disease: Cause or Effect
$
0.00
Add to cart
The validity of breath collection bags method in detecting Helicobacter pylori using the novel BreathID®Hp Lab System: a multicenter clinical study in 257 subjects
$
0.00
Add to cart
S242 Microbiome Changes Post Bovine IGG in Irritable Bowel Syndrome and Inflammatory Bowel Disease Patients
$
0.00
Add to cart
Ubiquitous Detection of Clostridioides difficile in Outpatient Gut Microbiome Using Next Generation Shotgun Sequencing and Metagenomic Analysis: NonToxigenic C. difficile is Ubiquitous in Normal Population
$
0.00
Add to cart
Scroll To Top